Catalyst Wire Dossier Catalyst Wire Dossier

HerpV vaccine with QS-21

HerpV vaccine with QS-21 · Agenus Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HerpV vaccine with QS-21, covering 2021-07-13 to 2021-07-13. Get the full timeline:

Most recent: Clinical Trial Update: Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital Herpes [Phase 2]

See pricing